millaf – stock.adobe.com Ozempic is part of a class of diabetes and obesity drugs that mimic the GLP-1 hormone the body naturally produces after eating, suppressing appetite and stimulating weight loss. The University of Copenhagen scientists — funded ...

New weight loss drug target reduces appetite and burns calories without sickness - The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well to current treatments.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.